• Sorafenib and the Next Frontier in Liver Cancer Biology

  2026-10-07

  A mechanistic and translational perspective on Sorafenib (BAY-43-9006), its value as a cancer biology research tool, and how recent findings on cholesterol-driven mitophagy broaden research questions in hepatocellular carcinoma.

• Gut Dysbiosis and α-Synuclein Pathology in Parkinson’s

  2026-10-07

  This mouse study connects rotenone-associated gut microbiota dysbiosis with intestinal barrier disruption, inflammation, C/EBPβ/AEP signaling, α-synuclein pathology, and motor deficits. Its microbiota-depletion and fecal-transfer comparisons provide intervention-based evidence that the gut microbiome can modify pathology in this Parkinson’s disease model, while leaving important questions about human relevance unresolved.

• RISOTTO Trial: Risedronate in RA-Related GIO

  2026-10-06

  The RISOTTO study evaluated sodium risedronate in 95 patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis in a multicentre, randomized, double-blind, placebo-controlled trial. Risedronate produced a significantly larger six-month increase in lumbar spine bone mineral density, while effects at the femoral neck and total hip were not significant and safety findings require longer follow-up.

• SMYD2 Inhibition in Cisplatin-Related Renal Fibrosis

  2026-10-06

  A 2023 study investigated whether pharmacological inhibition of SMYD2 could reduce cisplatin-associated renal fibrosis and inflammation. Using an in vivo injury model and cultured tubular epithelial cells, the authors linked SMYD2 inhibition with improved renal injury readouts, reduced fibrotic and inflammatory markers, and altered Smad3, STAT3, and Smad7 signaling.

• Docking-Based Vitamin Repurposing for COVID-19

  2026-10-05

  The 2022 Journal of Molecular Modeling study by Eskandari used virtual screening, molecular docking, and molecular dynamics simulations to examine vitamin-related compounds against SARS-CoV-2 3CLpro and the spike receptor-binding domain. Its findings nominate several compounds for further antiviral therapeutics research, but the computational evidence does not establish biochemical inhibition, antiviral activity, or clinical benefit.

• Berberine Hydrochloride and the Metabolic–Inflammation Axis

  2026-10-05

  Berberine hydrochloride is best understood as a translational research probe at the intersection of energy sensing, lipid metabolism, cell survival, and inflammation. This article connects its reported AMPK and LDLR-related biology with findings from a 2025 acute kidney injury study that identifies oxidized self-DNA, STING, NLRP3, and A20–NEK7 signaling as an inflammatory network, while clarifying what remains hypothesis rather than established mechanism.

• 2'3'-cGAMP in STING-Mediated Innate Immunity

  2026-10-04

  A source-grounded overview of 2'3'-cGAMP and its role as a direct STING pathway agonist, with emphasis on conceptual applications, the REC8 innate-immunity study, evidence strength, and limits on translating pathway findings to antiviral or immunotherapy claims.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Evidence Guide

  2026-10-03

  The Cy5 Goat Anti-Mouse IgG (H+L) Antibody can function as more than a fluorescence reagent: it is a measurement layer for interpreting vaccine-antigen studies. This evidence-focused guide connects secondary-antibody biology with ferritin-based hybrid vaccine findings while defining applicability limits.

• HyperFluor 488 Goat Anti-Rabbit IgG Guide

  2026-10-02

  HyperFluor 488 Goat Anti-Rabbit IgG is a fluorescent antibody conjugate for detecting rabbit primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, flow cytometry, and fluorescence microscopy. Use it only in validated rabbit-primary workflows; the product dossier does not establish a universal dilution, performance limit, or suitability for live-cell applications, and its sodium azide preservative may be incompatible with some assays.

• 2'3'-cGAMP for STING Assay Workflows

  2026-10-01

  Use 2'3'-cGAMP (sodium salt) as a water-soluble, high-affinity reference agonist for mapping STING signaling, type I interferon induction, and macrophage phagocytosis. This workflow connects early TBK1–IRF3 responses with the nanocarrier-enabled SIRPα and CD47 findings reported in cancer immunotherapy research.

• Mianserin HCl: Receptor Assay Workflows

  2026-10-01

  Mianserin HCl is a practical 5-HT2 receptor antagonist for connecting serotonin receptor signaling pathway studies with translational antidepressant and antipathogenic assays. This guide turns its solvent, cyclodextrin, and comparator data into reproducible workflows, controls, and troubleshooting decisions.

• Indazole Glucagon Receptor Antagonists: Study Insights

  2026-09-30

  Lin et al. reported a novel indazole- and indole-based series of glucagon receptor antagonists derived from the MK-0893 program, combining systematic SAR with rat pharmacokinetic and humanized-mouse efficacy studies. The work illustrates how modular amide bond formation and scaffold diversification can support small-molecule glucose-lowering programs while identifying GRA 16d as an orally active tool compound.

• Annexin V-HF647/PI Apoptosis Kit Workflow

  2026-09-29

  Translate HOXC9–AKT/mTOR biology into a practical two-color apoptosis workflow for ESCC cell models. The Annexin V-HF647/PI readout distinguishes membrane-compromised cells from phosphatidylserine-exposing cells while supporting pathway perturbation, mitochondrial follow-up, and troubleshooting at the cytometer.

• 2'3'-cGAMP: Linking STING Binding to Delivery

  2026-09-29

  2'3'-cGAMP (sodium salt) is a high-affinity endogenous STING ligand for dissecting cGAS-STING signaling and type I interferon induction. This article focuses on the experimental gap between molecular potency and intracellular delivery, using recent lipid nanoparticle research to guide assay design.

• Indometacin Sodium: Applied Assay Workflows

  2026-09-28

  Turn Indometacin Sodium into a controlled perturbation tool for inflammation, prostaglandin, oligodendrocyte, and pancreatic stellate cell studies. This workflow pairs mechanism-aware dosing with endpoint discipline, solvent controls, and troubleshooting guidance for more reproducible translational assays.

8014 records 1/535 page Next 12345 下5页 Last page